NASDAQ:EVOP EVO Payments (EVOP) Stock Price, News & Analysis → Jim Cramer’s “The Biggest Drug Ever” (From Behind the Markets) (Ad) Free EVOP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$33.99▼$33.9950-Day Range$33.70▼$33.9952-Week Range$21.01▼$34.01VolumeN/AAverage Volume668,889 shsMarket Capitalization$1.76 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EVO Payments alerts: Email Address Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... About EVO Payments Stock (NASDAQ:EVOP)EVO Payments, Inc. is a holding company, which provides payment technology and services. The firm offers payment and commerce solutions. It operates through the Americas and Europe geographical segments. The Americas segment consists of the United States, Canada, Mexico, and Chile. The Europe segment includes operations in Poland, Germany, Ireland, the United Kingdom, Spain, and the Czech Republic, as well as support of merchants in surrounding markets. The company was founded by Rafik R. Sidhom in 1989 and is headquartered in Atlanta, GA.Read More Ad Behind the MarketsJim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.Unlock the details of this groundbreaking opportunity here... EVOP Stock News HeadlinesApril 26, 2024 | msn.comEvotec SE (NASDAQ:EVO) Q4 2023 Earnings Call TranscriptApril 25, 2024 | seekingalpha.comEvotec SE (EVO) Q4 2023 Earnings Call TranscriptApril 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.April 22, 2024 | reuters.comTimeline of Donald Trump-Stormy Daniels hush money caseNovember 7, 2023 | markets.businessinsider.comEQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncologyNovember 7, 2023 | nasdaq.comEvotec To Facilitate Development Of Dewpoint's Oncology Assets Using INDiGO PlatformOctober 24, 2023 | investing.comEVOP Historical DataOctober 5, 2023 | abcnews.go.comStudent loan payments restarted on Oct. 1. Here's what to knowApril 26, 2024 | Behind the Markets (Ad)Jim Cramer’s “The Biggest Drug Ever”This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.August 24, 2023 | bbc.comCost-of-living payments: Who is getting them and when?August 16, 2023 | technews.tmcnet.comABC Evo Unveils Cutting-Edge CRM and Business Intelligence Solutions to Enhance Its Club Management SoftwareJuly 5, 2023 | msn.comEvotec Secures US Government Contract For Orthopoxvirus AntibodyJune 30, 2023 | usatoday.comAutomatic bill payments: How it works?June 29, 2023 | markets.businessinsider.comEQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programmeJune 20, 2023 | abcnews.go.comThe student loan challenge: Here's what to do when payments resumeMay 10, 2023 | msn.comNovartis' Sandoz to use Evotec's technology in pact to develop biosimilarsMay 2, 2023 | time.comHow to Calculate Loan Payments and CostsMarch 29, 2023 | nasdaq.comDaily Markets: Stocks Attempt to RallyFebruary 28, 2023 | finance.yahoo.com15 Biggest Payment Companies in the WorldFebruary 22, 2023 | uk.finance.yahoo.comEVO Payments Inc (E19.SG)January 29, 2023 | nasdaq.comGreenhouse Funds LLLP Cuts Stake in EVO Payments Inc (EVOP)December 20, 2022 | finance.yahoo.comEVO Payments (EVOP) Shares Rose by 42% in Q3December 13, 2022 | finance.yahoo.comParallaxes Capital Highlights Previously Terminated TRA of a Leading Payment ProviderNovember 2, 2022 | finance.yahoo.comEVO Reports Third Quarter 2022 ResultsOctober 19, 2022 | finance.yahoo.comEVO Payments to Release Third Quarter 2022 Financial ResultsOctober 17, 2022 | benzinga.comEVO PAYMENTS (EVOP) SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of EVO Payments, Inc.October 13, 2022 | benzinga.comEVOP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of EVO Payments, Inc. Is Fair to ShareholdersSee More Headlines Receive EVOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EVO Payments and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/03/2021Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Business services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:EVOP CUSIPN/A CIK1704596 Webwww.evopayments.com Phone(770) 336-8463FaxN/AEmployees2,400Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$5.28 million Net Margins0.97% Pretax Margin10.41% Return on Equity-7.74% Return on Assets3.67% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio1.10 Sales & Book Value Annual Sales$543.08 million Price / Sales3.24 Cash Flow$1.75 per share Price / Cash Flow19.41 Book Value($21.85) per share Price / Book-1.56Miscellaneous Outstanding Shares51,740,000Free Float45,142,000Market Cap$1.76 billion OptionableNot Optionable Beta1.11 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesJames G. KellyChief Executive Officer & DirectorThomas E. PantherChief Financial Officer & Executive Vice PresidentMichael L. ReidenbachChief Information Officer & Executive VPCatherine H. LafiandraChief Human Resources Officer & Executive VPKelli E. SterrettSecretary, Executive VP & General CounselKey CompetitorsCardtronicsNASDAQ:CATMPayoneer GlobalNASDAQ:PAYOAdvantage SolutionsNASDAQ:ADVMediaAlphaNYSE:MAXWNSNYSE:WNSView All Competitors EVOP Stock Analysis - Frequently Asked Questions How were EVO Payments' earnings last quarter? EVO Payments, Inc. (NASDAQ:EVOP) issued its earnings results on Wednesday, November, 3rd. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.02. The business earned $135.04 million during the quarter, compared to the consensus estimate of $129.87 million. EVO Payments had a negative trailing twelve-month return on equity of 7.74% and a net margin of 0.97%. The company's revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.14 EPS. What is Jim Kelly's approval rating as EVO Payments' CEO? 78 employees have rated EVO Payments Chief Executive Officer Jim Kelly on Glassdoor.com. Jim Kelly has an approval rating of 47% among the company's employees. This puts Jim Kelly in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of EVO Payments own? Based on aggregate information from My MarketBeat watchlists, some companies that other EVO Payments investors own include KeyCorp (KEY), AT&T (T), General Mills (GIS), General Motors (GM), Marathon Petroleum (MPC), Stitch Fix (SFIX), Aptiv (APTV), Energy Transfer (ET), Gilead Sciences (GILD) and International Business Machines (IBM). When did EVO Payments IPO? EVO Payments (EVOP) raised $210 million in an initial public offering (IPO) on Wednesday, May 23rd 2018. The company issued 14,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, BofA Merrill Lynch, Citigroup, Deutsche Bank Securities, SunTrust Robinson Humphrey, Barclays, Cowen, Goldman Sachs, PKO BP Securities, Regions Securities and William Blair acted as the underwriters for the IPO. This page (NASDAQ:EVOP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EVO Payments, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
